Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients
Launched by SAINT PETERSBURG STATE UNIVERSITY, RUSSIA · Apr 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how using lung ultrasound can help doctors better understand and manage complications after heart surgery. Specifically, it aims to see if ultrasound is more effective than traditional methods like X-rays in spotting early problems with the lungs after surgery. Doctors will perform lung ultrasounds on patients during their first week after heart surgery and adjust treatments based on what they find. This could help improve recovery and reduce hospital stays for patients.
To join the study, participants need to be undergoing open heart surgery that requires a heart-lung machine between December 15, 2023, and December 15, 2024, and must agree to take part in the study by signing a consent form. However, those who have had previous heart surgeries, lung surgery, certain chronic diseases, or who are considered low risk for complications are not eligible. If you or a loved one qualifies, you can expect regular lung ultrasounds during the recovery period, and your treatment may be adjusted to help improve overall outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • open heart surgery with cardiopulmonary bypass (CPB) between 15 December 2023 and 15 December 2024
- • signed informed consent for participation in the study
- Exclusion Criteria:
- • reoperations on the open heart with CPB
- • surgical procedures on lungs and lung cancer in the anamnesis
- • chronic obstructive pulmonary disease, stage III
- • chronic kidney disease, stages 4 and 5
- • patients with low Risk Score profile by the Society of Thoracic Surgeons
About Saint Petersburg State University, Russia
Saint Petersburg State University, established in 1724, is a prestigious institution in Russia known for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes through rigorous scientific investigation. With a focus on multidisciplinary collaboration, the university fosters partnerships with healthcare professionals, researchers, and industry stakeholders to conduct high-quality clinical trials that adhere to international standards. Its mission is to contribute to the global healthcare landscape by generating reliable data that informs clinical practices and therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Petersburg, , Russian Federation
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported